dapi has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beker, AR; Bevers, MM; Colenbrander, B; Izadyar, F | 1 |
| Deguil, J; Fauconneau, B; Houeto, JL; Jailloux, D; Muller, JM; Page, G; Pain, S; Philippe, M | 1 |
2 other study(ies) available for dapi and vasoactive intestinal peptide
| Article | Year |
|---|---|
Effect of growth hormone releasing hormone (GHRH) and vasoactive intestinal peptide (VIP) on in vitro bovine oocyte maturation.
Topics: Animals; Cattle; Female; Fluorescent Dyes; Follicle Stimulating Hormone; Growth Hormone-Releasing Hormone; Indoles; Meiosis; Microscopy, Fluorescence; Oocytes; Ovary; Peanut Agglutinin; Random Allocation; Vasoactive Intestinal Peptide | 2000 |
Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in Neuro-2a neuroblastoma cells.
Topics: Animals; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Fluorescent Dyes; Indoles; Mice; MPTP Poisoning; Neuroblastoma; Neuropeptides; Neuroprotective Agents; Phosphorylation; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Biosynthesis; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Vasoactive Intestinal Peptide | 2007 |